Services provided by the drug development and regulatory group will vary according to the individual needs of the investigators.

Drug Development & Regulatory

Services

Services provided by the drug development and regulatory group will vary according to the individual needs of the investigators. For example, services to help investigators could include:

  • Preclinical consultation
    • Develop an IND gap analysis and outline a plan to advance a compound to IND
  • Provide preclinical study support
    • Protocol design, and report writing
    • Evaluation of vendors and study monitoring
    • Assessment of qualification of excipients, impurities, extractables and leachables
    • Scientific and regulatory advice
  • Provide guidance for CMC activities
    • Drug substance and drug product manufacturing
    • Evaluation of manufacturers
    • Formulation development
    • Scientific and regulatory advice
  • Regulatory writing and consulting
    • Preparation of regulatory documents and FDA communications
    • FDA meeting support
    • Pre-Investigational New Drug Application (IND) briefing packages
    • Investigator brochures
    • Scientific and regulatory advice

Requesting support:

  • To request RTI support or more information, contact the Clinical Research Compliance Office (CRCO) at This email address is being protected from spambots. You need JavaScript enabled to view it..
  • To facilitate the request process, complete the RTI Regulatory Services Request Form (.docx) and submit to the CRCO.
NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact